UK markets closed
NIKKEI 225
38,236.07 -37.98 (-0.10%) HANG SENG
18,207.13 +444.10 (+2.50%) CRUDE OIL
78.96 -0.04 (-0.05%) GOLD FUTURES
2,312.50 +1.50 (+0.06%) DOW
38,225.66 +322.37 (+0.85%) Bitcoin GBP
47,151.13 +1,515.39 (+3.32%)
MorphoSys AG (0NDV.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
At close: 05:13PM BST
| Previous close | 66.50 |
| Open | 65.50 |
| Bid | 64.40 x 0 |
| Ask | 67.70 x 0 |
| Day's range | 65.43 - 66.10 |
| 52-week range | 8.40 - 68.35 |
| Volume | |
| Avg. volume | 175,974 |
| Market cap | 2.286B |
| Beta (5Y monthly) | 0.67 |
| PE ratio (TTM) | 26.31 |
| EPS (TTM) | 2.51 |
| Earnings date | 29 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WireMorphoSys AG Reports First Quarter 2024 Financial Results
PLANEGG/MUNICH, Germany, April 29, 2024--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the first quarter of 2024.
ZacksNovartis (NVS) Inks Deal for ARVN's Prostate Cancer Candidate
Novartis (NVS) enters into a license deal with Arvinas, Inc. (ARVN) for the worldwide development and commercialization of cancer candidate ARV-766. Shares of ARVN rise on the news.
- Zacks
Novartis (NVS) to Undertake Job Cuts in Development Department
Novartis (NVS) is set to cut jobs by 680 in its development organization to reshape workforce.
© 2024 Yahoo. All rights reserved.